Skip to main content
Clinical Trials/CTRI/2025/10/095730
CTRI/2025/10/095730
Not yet recruiting
Phase 3 4

A Comparitive Study To Assess The Effectiveness Of Homoeopathic Medicine Ammonium Phosphoricum And Formica Rufa In The Management Of Cases Of Rheumatoid Arthritis

Dr MPK Homoeopathic Medical College Hospital and Research Centre1 site in 1 country60 target enrollmentStarted: October 20, 2025Last updated:

Overview

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Enrollment
60
Locations
1
Primary Endpoint
Improvement according to scores obtained(pre and post treatment) from the Visual Analogue scale(VAS score)

Overview

Brief Summary

Aim : To evaluate and compare the effectiveness of Ammonium Phosphoricum and Formica Rufa in the management of Rheumatoid Arthritis. Objective:  To assess symptomatic improvement in RA patients using homoeopathic medicine.To compare the effectiveness of Ammonium Phosphoricum and Formica Rufa.

To observe changes in relevant clinical parameters (pain score, joint mobility, ESR, CRP, etc).

To study the improvement in quality of life using a validated scale (e.g., HAQ-DI).

To compare which one is more effective in Rheumatoid Arthritis.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Clinically diagnosed patients of Rheumatoid Arthritis.
  • Previously diagnosed cases of Rheumatoid arthritis reoccurring, despite other medicines with no avail.
  • Patients having CRP variations.
  • Patients giving consent and maintaining follow up.

Exclusion Criteria

  • Immuno-compromised patients such as those suffering from HIV, Hepatitis B/C, etc.
  • Pregnant women and lactating mothers will not be included in the study.
  • Cases with multi-systemic illness will be excluded from the study, and cases with advanced pathology.
  • Patients who are not willing to give informed consent.
  • Taking other treatments for RA.
  • Patients having extra-articular manifestations.

Outcomes

Primary Outcomes

Improvement according to scores obtained(pre and post treatment) from the Visual Analogue scale(VAS score)

Time Frame: Pre scores will be taken at baseline of treatment and post scores will be assessed at the end of 3 months

Secondary Outcomes

  • Symptomatic improvement in RA patients using homoeopathic medicine and changes in relevant clinical parameters (pain score, joint mobility, ESR, CRP,etc.) will be observed.(12 months)

Investigators

Sponsor
Dr MPK Homoeopathic Medical College Hospital and Research Centre
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Vikash Yadav

Dr MPK Homoeopathic Medical College Hospital and Research Centre

Study Sites (1)

Loading locations...

Similar Trials